financetom
Business
financetom
/
Business
/
Why Allurion Technologies Stock Is Racing Higher
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Allurion Technologies Stock Is Racing Higher
Apr 4, 2024 12:27 PM

Allurion Technologies, Inc. ( ALUR ) shares are trading higher Thursday after the company announced the commercial availability of its Virtual Care Suite (VCS) in the United States. 

The Details:

Allurion Technologies' ( ALUR ) Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP-1 and other anti-obesity medication therapy, bariatric surgery, and weight loss devices.  The company describes the VCS as a weight-loss management suite powered by artificial intelligence (AI) featuring remote patient monitoring, telehealth and care team collaboration. 

“After witnessing the profound impact our technology has had globally, we are thrilled to launch the VCS in the United States. Our team is incredibly excited to provide US clinics with digital solutions to help them significantly bolster both clinical outcomes and patient experience for all weight-loss treatments, including anti-obesity medications and bariatric surgery, especially as GLP-1 usage surges,” said Brian Conyer, Vice President of Digital Health. 

Chardan Capital analyst Keay Nakae initiated coverage on Allurion Technologies ( ALUR ) on Thursday with a Buy rating and a $5 price target.

Related News: Aurora Cannabis And Canopy Growth Stocks Get Higher: What’s Going On?

How To Buy ALUR Stock:

By now you're likely curious about how to participate in the market for Allurion Technologies ( ALUR ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

ALUR Price Action: According to Benzinga Pro, Allurion Technologies ( ALUR ) shares are up 59% at $2.75 at the time of publication Thursday.

Image: Parentingupstream from Pixabay

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wyndham Hotels & Resorts Q3 Adjusted Earnings Gain, Revenue Falls; 2024 EPS Guidance Raised
Wyndham Hotels & Resorts Q3 Adjusted Earnings Gain, Revenue Falls; 2024 EPS Guidance Raised
Oct 30, 2024
05:54 PM EDT, 10/23/2024 (MT Newswires) -- Wyndham Hotels & Resorts ( WH ) reported Q3 adjusted earnings late Wednesday of $1.39 per diluted share, up from $1.31 a year earlier. Analysts polled by Capital IQ expected normalized EPS of $1.38. Net revenue in the three months ended Sept. 30 fell to $396 million from $402 million a year earlier....
Knight-Swift Transportation Q3 Adjusted Earnings, Revenue Decline; EPS Guidance Set
Knight-Swift Transportation Q3 Adjusted Earnings, Revenue Decline; EPS Guidance Set
Oct 30, 2024
05:30 PM EDT, 10/23/2024 (MT Newswires) -- Knight-Swift Transportation ( KNX ) reported Q3 adjusted earnings late Wednesday of $0.34 per diluted share, down from $0.41 a year earlier. Analysts polled by Capital IQ expected $0.32. Revenue for the quarter that ended Sept. 30 was $1.88 billion, down from $2.02 billion a year earlier. Analysts surveyed by Capital IQ expected...
Centessa Pharmaceuticals Insider Sold Shares Worth $863,727, According to a Recent SEC Filing
Centessa Pharmaceuticals Insider Sold Shares Worth $863,727, According to a Recent SEC Filing
Oct 30, 2024
05:36 PM EDT, 10/23/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on October 21, 2024, sold 55,000 shares in Centessa Pharmaceuticals ( CNTA ) for $863,727. Following the Form 4 filing with the SEC, Saha has control over a total of 668,661 shares of the company, with 630,661 shares held directly and 38,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000160/xslF345X05/wk-form4_1729718836.xml...
Bancfirst Insider Sold Shares Worth $617,271, According to a Recent SEC Filing
Bancfirst Insider Sold Shares Worth $617,271, According to a Recent SEC Filing
Oct 30, 2024
05:36 PM EDT, 10/23/2024 (MT Newswires) -- Leslie Jeannine Rainbolt, 10% Owner, Director, on October 23, 2024, sold 5,601 shares in Bancfirst ( BANF ) for $617,271. Following the Form 4 filing with the SEC, Rainbolt has control over a total of 4,940,171 shares of the company, with 4,940,171 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/760498/000159396824001281/xslF345X05/primary_01.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved